|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.760 CNY | -3.34% |
|
+4.16% | -15.12% |
| Market Cap | 4.47B 660M 577M 532M 491M 925M 63.55B 945M 6.36B 2.5B 31.13B 2.48B 2.42B 107B | P/E 2024 |
18.6x | P/E 2025 | 73.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.24B 625M 546M 504M 465M 876M 60.2B 895M 6.03B 2.37B 29.48B 2.35B 2.3B 101B | EV / Sales 2024 |
2.15x | EV / Sales 2025 | 2.9x |
| Free-Float |
68.44% | Yield 2024 |
1.12% | Yield 2025 | 1.58% |
| 1 day | -3.34% | ||
| 1 week | +4.16% | ||
| Current month | +11.24% | ||
| 1 month | +7.43% | ||
| 3 months | -10.05% | ||
| 6 months | -17.00% | ||
| Current year | -15.12% |
| 1 week | 3.57 |  | 3.92 |
| 1 month | 3.24 | | 3.92 |
| Current year | 3.24 | | 4.75 |
| 1 year | 3.24 | | 5.48 |
| 3 years | 2.92 | | 5.68 |
| 5 years | 2.92 | | 5.68 |
| 10 years | 2.87 | | 11.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lu Wang
CEO | Chief Executive Officer | 42 | 2023-12-03 |
Xue Song Yu
DFI | Director of Finance/CFO | 57 | 2009-09-18 |
Qin Tang
SEC | Corporate Secretary | 57 | 2009-09-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhi Dong
BRD | Director/Board Member | 66 | 2024-11-19 |
Tian Xiang Wang
CHM | Chairman | 70 | 2009-09-18 |
Lu Wang
BRD | Director/Board Member | 42 | 2021-12-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.34% | +4.16% | -18.08% | -3.84% | 660M | |
| -0.90% | -0.15% | +14.11% | +81.10% | 48.15B | |
| -0.23% | -1.65% | +67.15% | +112.03% | 35.59B | |
| -0.76% | -1.44% | -4.29% | +37.63% | 11.9B | |
| -0.88% | -0.62% | +17.31% | +89.97% | 11.85B | |
| +0.19% | +2.87% | +34.92% | +139.73% | 9.31B | |
| +3.37% | -0.10% | +51.64% | -3.75% | 7.02B | |
| -0.75% | -0.91% | +17.45% | +37.70% | 6.91B | |
| -2.25% | -2.08% | +0.45% | +209.99% | 6.55B | |
| -9.93% | +0.35% | -31.51% | +16.58% | 6.13B | |
| Average | -1.55% | +0.28% | +14.92% | +71.71% | 14.41B | |
| Weighted average by Cap. | -0.89% | -0.41% | +26.58% | +86.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.39B 353M 308M 285M 262M 494M 33.98B 505M 3.4B 1.34B 16.64B 1.33B 1.3B 57.28B | 1.74B 256M 224M 207M 191M 359M 24.7B 367M 2.47B 972M 12.1B 963M 942M 41.64B |
| Net income | 280M 41.28M 36.08M 33.29M 30.69M 57.84M 3.98B 59.12M 398M 157M 1.95B 155M 152M 6.7B | 77M 11.36M 9.93M 9.16M 8.44M 15.91M 1.09B 16.27M 109M 43.07M 536M 42.66M 41.72M 1.84B |
| Net Debt | -171M -25.16M -21.99M -20.29M -18.7M -35.25M -2.42B -36.03M -243M -95.39M -1.19B -94.49M -92.42M -4.09B | -236M -34.85M -30.46M -28.11M -25.91M -48.83M -3.36B -49.91M -336M -132M -1.64B -131M -128M -5.66B |
Employees
2,988
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | CN¥3.760 | -3.34% | 26,945,705 |
| 26-07-16 | CN¥3.890 | +1.30% | 31,072,338 |
| 26-07-15 | CN¥3.840 | +2.40% | 33,900,828 |
| 26-07-14 | CN¥3.750 | +1.90% | 24,786,528 |
| 26-07-13 | CN¥3.680 | +1.94% | 30,561,728 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300194 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
